Patents by Inventor Kin-Sang Cho

Kin-Sang Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240025986
    Abstract: The invention provides compositions and methods for treating optic neuropathic disorders.
    Type: Application
    Filed: May 16, 2023
    Publication date: January 25, 2024
    Inventors: Dong Feng Chen, Ji Min, Kin-Sang Cho
  • Patent number: 11826341
    Abstract: A method of treating an ocular nerve injury in a subject in need thereof, the method comprising administering a therapeutically effective amount of baicalein or an analog thereof.
    Type: Grant
    Filed: February 9, 2022
    Date of Patent: November 28, 2023
    Assignees: THE HONG KONG POLYTECHNIC UNIVERSITY
    Inventors: Chi Wai Do, Chi ho To, Li Pan, Dongfeng Chen, Kin-Sang Cho
  • Patent number: 11692029
    Abstract: The invention provides compositions and methods for treating optic neuropathic disorders.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: July 4, 2023
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Ji Min, Kin-Sang Cho, Dong Feng Chen
  • Patent number: 11622951
    Abstract: The invention provides compositions and methods for preserving, restoring, or enhancing vision of a subject by administering compositions to an injured or diseased eye.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: April 11, 2023
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Dong Feng Chen, Kin-Sang Cho
  • Publication number: 20220249432
    Abstract: A method of treating an ocular nerve injury in a subject in need thereof, the method comprising administering a therapeutically effective amount of baicalein or an analog thereof.
    Type: Application
    Filed: February 9, 2022
    Publication date: August 11, 2022
    Inventors: Chi Wai DO, Chi ho TO, Li PAN, Dongfeng CHEN, Kin-Sang CHO
  • Publication number: 20220143139
    Abstract: Compositions and methods for treating and/or reducing risk of development or progression of neuroinflammation and neurodegeneration, comprising HSP60 e.g., for nasal administration, and IGFBPL1, e.g., for nasal, systemic, or ocular, e.g., intravitreal, administration.
    Type: Application
    Filed: March 3, 2020
    Publication date: May 12, 2022
    Inventors: Dong Feng Chen, Kin-Sang Cho, Min Ji
  • Publication number: 20210068650
    Abstract: Methods, systems, and devices are provided for assessing visual function, especially in animals. For example, a device can be used for assessing visual functions, such as PLR and OMR, in animals that includes a visual stimulus unit. The device can also include one or more input devices that include at least one camera that is configured to monitor movement of the test subject and a processor that is configured to analyze the movement of the test subject taken by the camera and to assess visual functions of the test subject. The device can be used in a system including a designated general location for the test subject in which the test subject can see the visual stimulus unit and move freely while being monitored by the camera.
    Type: Application
    Filed: April 3, 2019
    Publication date: March 11, 2021
    Inventors: Dong Feng Chen, Gang Luo, Cong Shi, Kin-Sang Cho
  • Publication number: 20210059969
    Abstract: The invention provides compositions and methods for preserving, restoring, or enhancing vision of a subject by administering compositions to an injured or diseased eye.
    Type: Application
    Filed: August 13, 2020
    Publication date: March 4, 2021
    Inventors: Dong Feng Chen, Kin-Sang Cho
  • Publication number: 20200399361
    Abstract: The invention provides compositions and methods for treating optic neuropathic disorders.
    Type: Application
    Filed: March 5, 2019
    Publication date: December 24, 2020
    Inventors: Ji Min, Kin-Sang Cho, Dong Feng Chen
  • Patent number: 10780070
    Abstract: The invention provides compositions and methods for preserving, restoring, or enhancing vision of a subject by administering compositions to an injured or diseased eye.
    Type: Grant
    Filed: October 20, 2014
    Date of Patent: September 22, 2020
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Dong Feng Chen, Kin-Sang Cho
  • Publication number: 20160271091
    Abstract: The invention provides compositions and methods for preserving, restoring, or enhancing vision of a subject by administering compositions to an injured or diseased eye.
    Type: Application
    Filed: October 20, 2014
    Publication date: September 22, 2016
    Inventors: Dong Feng Chen, Kin-Sang Cho
  • Publication number: 20050152995
    Abstract: Provided herein are methods and compositions for rendering a cellular environment permissive to axon regeneration and neural cell transplantation. Methods for stimulating axon regeneration in adult subjects are also disclosed. The methods may comprise contacting a tissue with an agent that prevents glial scar formation, such as by inhibiting reactive astroglial cells, and optionally an agent that increases bcl-2 protein levels in neural cells. Exemplary agents include astrotoxin for inhibiting reactive astroglial cells and lithium for increasing bcl-2 protein levels.
    Type: Application
    Filed: June 25, 2004
    Publication date: July 14, 2005
    Inventors: Dong Chen, Kin-Sang Cho, Masumi Takeda, Reiko Kinouchi